6-30602635-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002714.4(PPP1R10):c.2014C>T(p.Pro672Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000251 in 1,594,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000067 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000027 ( 0 hom. )
Consequence
PPP1R10
NM_002714.4 missense
NM_002714.4 missense
Scores
1
3
14
Clinical Significance
Conservation
PhyloP100: 3.62
Genes affected
PPP1R10 (HGNC:9284): (protein phosphatase 1 regulatory subunit 10) This gene encodes a protein phosphatase 1 binding protein. The encoded protein plays a role in many cellular processes including cell cycle progression, DNA repair and apoptosis by regulating the activity of protein phosphatase 1. This gene lies within the major histocompatibility complex class I region on chromosome 6, and alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.24819204).
BS2
High AC in GnomAdExome4 at 39 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP1R10 | NM_002714.4 | c.2014C>T | p.Pro672Ser | missense_variant | 19/20 | ENST00000376511.7 | NP_002705.2 | |
PPP1R10 | NM_001376195.1 | c.2014C>T | p.Pro672Ser | missense_variant | 19/20 | NP_001363124.1 | ||
PPP1R10 | XM_011514722.2 | c.2014C>T | p.Pro672Ser | missense_variant | 20/21 | XP_011513024.1 | ||
PPP1R10 | NR_072994.2 | n.2505C>T | non_coding_transcript_exon_variant | 19/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPP1R10 | ENST00000376511.7 | c.2014C>T | p.Pro672Ser | missense_variant | 19/20 | 1 | NM_002714.4 | ENSP00000365694.2 |
Frequencies
GnomAD3 genomes AF: 0.00000672 AC: 1AN: 148766Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
148766
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000359 AC: 8AN: 223044Hom.: 0 AF XY: 0.0000407 AC XY: 5AN XY: 122716
GnomAD3 exomes
AF:
AC:
8
AN:
223044
Hom.:
AF XY:
AC XY:
5
AN XY:
122716
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000270 AC: 39AN: 1445286Hom.: 0 Cov.: 32 AF XY: 0.0000195 AC XY: 14AN XY: 718452
GnomAD4 exome
AF:
AC:
39
AN:
1445286
Hom.:
Cov.:
32
AF XY:
AC XY:
14
AN XY:
718452
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000672 AC: 1AN: 148766Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 1AN XY: 72638
GnomAD4 genome
AF:
AC:
1
AN:
148766
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
72638
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.2014C>T (p.P672S) alteration is located in exon 19 (coding exon 17) of the PPP1R10 gene. This alteration results from a C to T substitution at nucleotide position 2014, causing the proline (P) at amino acid position 672 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Pathogenic
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at